Literature DB >> 26226734

[Study of effective components and molecular mechanism for Guizhi Fuling formula treatment of dysmenorrhea, pelvic inflammatory disease and uterine fibroids].

Zhi-peng Ke, Xin-zhuang Zhang, Yue Ding, Ze-yu Cao, Na Li, Liang Cao, Tuan-jie Wang, Chen-feng Zhang, Gang Ding, Zhen-zhong Wang, Wei Xiao, Xiao-jie Xu.   

Abstract

In this study, the active components and potential molecular .mechanism of Guizhi Fuling formula in treatment on dysmenorrhea, pelvic inflammation, and hysteromyoma were investigated using network pharmacological methods. Sterols and pentacyclic triterpenes, with high moleculal network degree, revealed promising effects on anti-inflammatory, analgesic, anti-tumor, and immune-regulation, according to D-T network analysis. On the other hand, the targets with high degree were involved in inflammatory, coagulation, angiopoiesis, smooth muscle contraction, and cell reproduction, which showed the novel function in anti-dysmenorrhea, pelvic inflammation, and hysteromyoma. Furthermore, the formula was indicated to play a key role in smooth muscle proliferation, inhibition of new vessels, circulation improvement, reduction of hormone secretion, alleviation of smooth muscle, block of arachidonic acid metabolism, and inflammation in uterus. Thus, the main mechanism of Guizhi Fuling formula was summarized. In conclusion, Guizhi Fuling formula was proven to alleviated dysmenorrhea, pelvic inflammation, and hysteromyoma by acting on multiple targets through several bioactive compounds, regulating 21 biological pathways.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26226734

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

Review 1.  Urological complications of uterine leiomyoma: a review of literature.

Authors:  Gautam Dagur; Yiji Suh; Kelly Warren; Navjot Singh; John Fitzgerald; Sardar A Khan
Journal:  Int Urol Nephrol       Date:  2016-02-27       Impact factor: 2.370

2.  Clinicopathological features and prognostic factors for uterine myoma.

Authors:  Xiaoli Wu; Yanqing Zheng
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.